Schwarz Pharma To Pay $50M To Settle Patent Suit Over Prilosec
In a patent settlement that has taken many observers by surprise, drug maker Mylan Laboratories Inc. will receive nearly $38 million from German rival Schwarz Pharma AG to end the companies'...To view the full article, register now.
Already a subscriber? Click here to view full article